DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 24 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-11-12: Reporting owner TUCK STEPHEN F; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-11-12: Reporting owner TUCK STEPHEN F; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-11-08: Reporting owner TUCK STEPHEN F; Form 3; Security Option (Right to Buy); Transaction Holding.
- 2010-11-08: Reporting owner TUCK STEPHEN F; Form 3; Security Option (Right to Buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-11-12 | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $1.98 exercise price | 2010-11-12 | |
| 2010-11-12 | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.98 exercise price | 2010-11-12 | |
| 2010-11-08 holding as of filing | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $1.50 exercise price | 2010-11-08 | ||
| 2010-11-08 holding as of filing | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $3.00 exercise price | 2010-11-08 | ||
| 2010-11-08 holding as of filing | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $7.49 exercise price | 2010-11-08 | ||
| 2010-11-08 holding as of filing | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $5.85 exercise price | 2010-11-08 | ||
| 2010-11-08 holding as of filing | TUCK STEPHEN F Officer (VP, Global Technical Ops) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $6.19 exercise price | 2010-11-08 | ||
| 2010-08-25 | MARTIN J TYLER Officer (President & CMO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +517,244 517,244 owned after | $1.72 exercise price | 2010-08-27 | |
| 2010-07-22 | KISNER DANIEL L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $2.02 exercise price | 2010-07-22 | |
| 2010-05-12 | Buc Nancy L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | CARSON DENNIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | GILBERT DENISE Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | LAWRENCE DAVID M Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | ORONSKY ARNOLD L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | Phillips Peggy V Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | Plotkin Stanley A Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | KESSEL MARK Director, 10% Owner | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-05-12 | CANO FRANCIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $1.88 exercise price | 2010-05-14 | |
| 2010-02-19 | OSTRACH MICHAEL S Officer (VP, CBO, and General Counsel) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.58 exercise price | 2010-02-23 | |
| 2010-02-19 | MARTIN J TYLER Officer (VP Clinical Development & CMO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.58 exercise price | 2010-02-23 | |
| 2010-02-19 | Lew Jennifer Officer (VP, Finance & PAO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $1.58 exercise price | 2010-02-23 | |
| 2010-02-19 | DINA DINO Director, Officer (President, CEO and Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $1.58 exercise price | 2010-02-23 | |
| 2010-02-19 | COFFMAN ROBERT Officer (Chief Scientific Officer & VP) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $1.58 exercise price | 2010-02-23 | |
| 2010-02-05 holding as of filing | MARTIN J TYLER Officer (VP Clinical Development & CMO) | 3 | Option (Right to Buy) Derivative · Direct | Holding | $0.58 exercise price | 2010-02-05 |